MarketInOut Stock Screener Log In | Sign Up
 

Milestone Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Milestone Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization80.7 mln
Float122 mln
Earnings Date11/17/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

17 / 100
Significantly lagging

Debt / Equity

7.79
Extremely leveraged

Pre-Tax Margin

-3,601%
Severely loss-making

ROE

-425
Deeply negative

Altman Z-Score

-3.64
Deeply distressed

Business Description

Milestone Pharmaceuticals is a Canadian company focused on bringing new heart medications to patients in North America. Its main product, CARDAMYST, is a nasal spray that helps adults quickly restore a normal heart rhythm during episodes of a rapid heartbeat condition known as PSVT. The company is also researching whether the same drug can treat another common heart rhythm disorder called atrial fibrillation, and works with partner Corxel Pharmaceuticals to advance these efforts.

Key Fundamentals

EPS-0.69
ROE-425
RPS0.02
ROIC-1,825
ROA-67.31
Interest Cover-7.27
EBITDA, mln-73.39
EV / EBITDA-1.34
EV / EBIT-1.34
Revenue, mln2.34
EV / Revenue41.96

Quote Details

Last 0.6482
Change -0.0545 (-7.76%)
Open 0.71
Volume 1,493,796
Turnover 968,278
Average Volume 972,590

Financial Ratios

Pre-Tax Profit Margin-3,601
Leverage Ratio9.97
Current Ratio8.13
Price / Book5.79
Price / Tangible Book5.79
Debt / Equity7.79
Price / Sales41.35

Financial Strength

Altman Z-Score-3.64
Piotroski F-Score 4 / 9
Short Ratio13.18
Short % of Float15.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.36% 11 / 100   
1 Month -18.46% 19 / 100   
2 Months -45.07% 10 / 100   
6 Months -65.7% 7 / 100   
1 Year -66.06% 13 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog